MESO

Mesoblast

• Benzinga·25m ago

  Full Transcript: Mesoblast FY 2026 Earnings Call

• Seeking Alpha·9h ago

  Here are the major earnings after the close Wednesday

• TipRanks·11h ago

  Largest borrow rate increases among liquid names

• Seeking Alpha·1d ago

  Mesoblast Q2 Earnings Preview

• TipRanks·1d ago

  Mesoblast Discloses Director Option Grant and New Equity Issues in August Filings

• Benzinga·5d ago

  Flowers Foods Posts Downbeat Q2 Results, Joins OSI Systems, Aveanna Healthcare And Other Big Stocks Moving Lower In Friday’s Pre-Market Session

• TipRanks·08/19 12:45

  Largest borrow rate increases among liquid names

• TipRanks·08/18 10:28

  Mesoblast Completes Pivotal Phase 3 Patient Treatment for Chronic Low Back Pain

• Benzinga·08/17 17:45

  Mesoblast Targets $10 Billion Market With Regenerative Back Pain Treatment

• Benzinga·08/17 13:51

  H World Group Posts Upbeat Q2 Results, Joins Almonty Industries, Diana Shipping And Other Big Stocks Moving Higher On Monday

• Seeking Alpha·08/17 11:25

  At a glance: stocks gapping up premarket

• TipRanks·08/17 00:50

  Mesoblast completes patient treatment in MSB-DR004 in Phase 3 trial

• Benzinga·08/14 12:06

  Swarmer Posts Downbeat Q2 Results, Joins TSS, ARS Pharmaceuticals, Globant And Other Big Stocks Moving Lower In Friday’s Pre-Market Session

• TipRanks·07/30 12:49

  Mesoblast Posts US$115m First-Year Ryoncil Sales and Advances Late-Stage Cell Therapy Pipeline

• TipRanks·07/28 12:45

  Largest borrow rate increases among liquid names